Related Experiment Video
Updated: Jul 6, 2025
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
The China Hypertrophic Cardiomyopathy Project (CHCMP): The Rationale and Design of a Multicenter, Prospective,
Zhi Du1, Kai Wang1, Yawei Cui1
1Department of Cardiology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Insights
This study identifies risk factors for sudden cardiac death (SCD) in Chinese patients with hypertrophic cardiomyopathy (HCM). Machine learning will create new predictive equations to improve risk stratification for better patient outcomes.
Area of Science:
- Cardiology
- Genetics
- Public Health
Background:
- Hypertrophic cardiomyopathy (HCM) increases risks of heart failure, arrhythmia, and mortality.
- Sudden cardiac death (SCD) is a primary cause of mortality in HCM patients, necessitating accurate risk identification.
Purpose of the Study:
- To identify prognostic factors for adverse outcomes in Chinese HCM patients.
- To develop novel 5-year SCD risk predictive equations using machine learning for Chinese HCM patients.
Main Methods:
- A prospective, multicenter, hospital-based registry cohort study of 3000 HCM patients.
- Comprehensive collection of demographic and clinical data.
- Application of machine learning technologies for predictive modeling.
Main Results:
- Analysis of demographic and clinical data to pinpoint prognostic factors.
- Development of new machine learning-based predictive equations for 5-year SCD risk.
- Validation of predictive models for Chinese HCM population.
Conclusions:
- The study provides crucial insights for risk stratification in Chinese HCM patients.
- The developed predictive equations aim to improve the identification of high-risk individuals for adverse outcomes.
- This research supports personalized risk assessment and management strategies for hypertrophic cardiomyopathy.
Abstract:
Hypertrophic cardiomyopathy (HCM) is associated with adverse outcomes, such as heart failure, arrhythmia, and mortality. Sudden cardiac death (SCD) is a common cause of death in HCM patients, and identification of patients at a high risk of SCD is crucial in clinical practice. The China Hypertrophic Cardiomyopathy Project is a hospital-based, multicenter, prospective, registry cohort study of HCM patients, covering a total of 3000 participants and with a 5-year follow-up plan. A large number of demographic characteristics and clinical data will be fully collected to identify prognostic factors in Chinese HCM patients. Furthermore, the main purpose of this study is to integrate demographic and clinical characteristics to establish new 5-year SCD risk predictive equations for Chinese HCM patients by the use of machine learning technologies. The project has crucial clinical significance for risk stratification and determination of HCM patients with high risk of adverse outcomes. CLINICAL TRIALS REGISTRATION: ChiCTR2300070909.
